Browse studies, page 386
Page 386 of 1,298, newest first. Search them all at once, ranked by relevance, in Evidence Hub.
- Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole Gut, 1997
- Comparative study of omeprazole, lansoprazole, pantoprazole and esomeprazole for symptom relief in patients with reflux esophagitis World Journal of Gastroenterology, 2009
- Preventive and therapeutic significance of octreotide combined with lansoprazole on post-ERCP pancreatitis and its effect on serum amylase, inflammatory factors and immune function Experimental and Therapeutic Medicine, 2021
- Letter: lansoprazole consumption is more common in Japanese patients with collagenous colitis Alimentary Pharmacology and Therapeutics, 2013
- Lansoprazole promotes cisplatin-induced acute kidney injury via enhancing tubular necroptosis Journal of Cellular and Molecular Medicine, 2021
- Upregulation of ribosome complexes at the blood-brain barrier in Alzheimer's disease patients Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2022
- Esomeprazole covalently interacts with the cardiovascular enzyme dimethylarginine dimethylaminohydrolase: Insights into the cardiovascular risk of proton pump inhibitors Biochimica et biophysica acta. General subjects, 2022
- Clozapine-induced stercoral colitis: a surgical perspective BMJ case reports, 2019
- Role of Vitamin B12 and Folate in Metabolic Syndrome Cureus, 2021
- Effect of long-term proton pump inhibitor administration on gastric mucosal atrophy: A meta-analysis Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association, 2017
- High-Salt Diet Exacerbates H. pylori Infection and Increases Gastric Cancer Risks Journal of personalized medicine, 2023
- Design, Synthesis and Anticancer Activity of a New Series of N-aryl-N'-[4-(pyridin-2-ylmethoxy)benzyl]urea Derivatives Molecules (Basel, Switzerland), 2021
- The Effects of Antibiotics for Helicobacter pylori Eradication or Dapsone on Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis Antibiotics (Basel, Switzerland), 2021
- Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people The Cochrane database of systematic reviews, 2016
- Sequence-based drug design as a concept in computational drug design Nature communications, 2023
- Sex-specific effects of Eugenia punicifolia extract on gastric ulcer healing in rats World journal of gastroenterology, 2018
- Effects of the herbal medicine Rikkunshito, for functional dyspepsia: A systematic review and meta-analysis Journal of gastroenterology and hepatology, 2021
- AΙ-Driven Drug Repurposing: Applications and Challenges Medicines (Basel, Switzerland), 2025
- Natural Products Derived from Marine Sponges with Antitumor Potential against Lung Cancer: A Systematic Review Marine drugs, 2024
- Efficacy of Helicobacter pylori Eradication Therapy on Platelet Recovery in Pediatric Immune Thrombocytopenic Purpura-Case Series and a Systematic Review Microorganisms, 2020
- Drug dosing in the critically ill obese patient: a focus on medications for hemodynamic support and prophylaxis Critical care (London, England), 2021
- Investigation of Potent Anti-Mycobacterium tuberculosis Agents Derived from Pyridine Derivatives Targeting the Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Computational Analysis Drug design, development and therapy, 2026
- The Effects of Proton Pump Inhibitors in Acid Hypersecretion-Induced Vitamin B12 Deficiency: A Systematic Review (2022) Cureus, 2022
- Tablet of Spondias mombin L. Developed from Nebulized Extract Prevents Gastric Ulcers in Mice via Cytoprotective and Antisecretory Effects Molecules (Basel, Switzerland), 2021
- Safe use of proton pump inhibitors in patients with cirrhosis British journal of clinical pharmacology, 2018
- Benzimidazole compound abrogates SARS-COV-2 receptor-binding domain (RBD)/ACE2 interaction In vitro Microbial pathogenesis, 2023
- Stereoselective Biotransformation: Transfer of Learning to Advance Drug Metabolism and Biocatalysis Angewandte Chemie (International ed. in English), 2026
- Developing guidance for feeding tube administration of oral medications JPEN. Journal of parenteral and enteral nutrition, 2023
- Computational, In Vitro, and In Vivo Evaluation of Benzimidazole-Pyrazole Hybrid Scaffolds as Multi-Target Anti-Ulcer Agents Chemistry & biodiversity, 2026
- Acute Budd-Chiari syndrome caused by inferior vena cava compression from a congenital diaphragmatic hernia Annals of the Royal College of Surgeons of England, 2020
- Discovery and optimization of a novel non-nitrocatechol COMT inhibitor for modulating levodopa metabolism Journal of pharmaceutical analysis, 2026
- Discovery of novel anti-Toxoplasma gondii agent derived from thiazolidinone-isatin hybrids: synthesis, biological assessment, and computational modeling RSC advances, 2026
- Severe Cutaneous Adverse Reactions Associated With Newer-Generation Antiseizure Medications: A Real-World Pharmacovigilance Study Based on FAERS and JADER CNS neuroscience & therapeutics, 2026
- Oral Antacid Use Is Negatively Associated with Serum Prealbumin Levels in Japanese Individuals Undergoing Health Checkups Nutrients, 2024
- Amelioration of obsessive-compulsive disorder by intracellular acidification of cortical neurons with a proton pump inhibitor Translational psychiatry, 2024
- Comparing the Safety and Efficacy of Proton Pump Inhibitors and Histamine-2 Receptor Antagonists in the Management of Patients With Peptic Ulcer Disease: A Systematic Review Cureus, 2023
- Inappropriate Use of Proton Pump Inhibitor Among Elderly Patients in British Columbia: What are the Long-term Adverse Events? Current drug safety, 2024
- Discovery of orally active and serine-targeting covalent inhibitors against hCES2A for ameliorating irinotecan-triggered gut toxicity Acta pharmaceutica Sinica. B, 2025
- Unravelling Voriconazole's Hepatic Metabolism: A Narrative Review on Factors Impacting Voriconazole-N-Oxide Exposure Mycoses, 2026
- Potassium-competitive acid blockers, a new therapeutic class, and their role in acid-related diseases: a narrative review Przeglad gastroenterologiczny, 2023
- Human genetic evidence enriched for side effects of approved drugs PLoS genetics, 2025
- The Potential of Authorised Drugs to be Repurposed for the Treatment of Osteoarthritis: A Scoping Review of Clinical Studies Drugs, 2026
- A multi-compartment pulsatile drug delivery system for sequential release: in vitro and in vivo evaluation Drug delivery and translational research, 2026
- Protective effects of antidepressants against ulcerogenic agents: insights from nonclinical studies Inflammopharmacology, 2026
- Pharmacokinetics of lansoprazole in hemodialysis patients Journal of clinical pharmacology, 1995
- Inhibitory activities of lansoprazole against respiration in Helicobacter pylori Antimicrobial agents and chemotherapy, 2001
- The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non-encapsulated granules Alimentary pharmacology & therapeutics, 1998
- Lansoprazole--profile of a new proton pump inhibitor Leber, Magen, Darm, 1994
- Lansoprazole enhances the antidiabetic effect of sitagliptin in mice with diet-induced obesity and healthy human subjects The Journal of pharmacy and pharmacology, 2014
- Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer Clinical therapeutics, 1993
- Stereoselective metabolism of lansoprazole by human liver cytochrome P450 enzymes Drug metabolism and disposition: the biological fate of chemicals, 2003
- Lansoprazole overutilization: methods for step-down therapy The American journal of managed care, 2003
- Laparoscopic fundoplication versus lansoprazole for gastro-oesophageal reflux disease. A pH-metric comparison Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2002
- Treatment of patients with Zollinger-Ellison syndrome Clinical therapeutics, 1993
- Adjuvant therapy for Helicobacter pylori eradication: role of lansoprazole in clinical studies Journal of clinical gastroenterology, 1995
- Proton pump inhibitor therapy: preliminary results of a therapeutic interchange program The American journal of managed care, 2000
- An open trial of long-term therapy with lansoprazole in patients with peptic ulceration resistant to extended high-dose ranitidine treatment Alimentary pharmacology & therapeutics, 1993
- Demography and treatment response in patients with predominant non-erosive reflux disease or functional dyspepsia Journal of gastroenterology and hepatology, 2015
- Influence of H pylori on plasma ghrelin in patients without atrophic gastritis World journal of gastroenterology, 2007
- Assessing pharmacokinetic differences in Caucasian and East Asian (Japanese, Chinese and Korean) populations driven by CYP2C19 polymorphism using physiologically-based pharmacokinetic modelling European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2019
- Proton pump inhibitors should not be used to treat persistent throat symptoms BMJ (Clinical research ed.), 2022
- Helicobacter pylori eradication: modified triple therapy with lansoprazole Fortschritte der Medizin, 1996
- Changes in bone turnover markers in adolescents with gastroesophageal reflux disease treated with lansoprazole Acta gastro-enterologica Belgica, 2022
- Lansoprazole oro-dispersible tablet : pharmacokinetics and therapeutic use in acid-related disorders Drugs, 2005
- Inhibition of monoglyceride lipase by proton pump inhibitors: investigation using docking and in vitro experiments Pharmacological reports : PR, 2020
- A Meta-Analysis and Systematic Review of the Efficacy of Twice Daily PPIs versus Once Daily for Treatment of Gastroesophageal Reflux Disease Gastroenterology Research and Practice, 2017
- Clopidogrel-Proton Pump Inhibitor Drug-Drug Interaction and Risk of Adverse Clinical Outcomes Among PCI-Treated ACS Patients: A Meta-analysis Journal of Managed Care & Specialty Pharmacy, 2016
- Probiotic supplementation does not improve eradication rate of Helicobacter pylori infection compared to placebo based on standard therapy: a meta-analysis Scientific Reports, 2016
- Efficiency of the Inclusion of Rebamipide in the Eradication Therapy for Helicobacter pylori Infection: Meta-Analysis of Randomized Controlled Studies Journal of Clinical Medicine, 2019
- Treatment of laryngopharyngeal reflux disease: A systematic review World Journal of Clinical Cases, 2019
- Incidence and type of adverse events in patients taking vonoprazan: A systematic review and meta-analysis Therapeutic Advances in Gastroenterology, 2023
- A systematic review of symptomatic outcomes used in oesophagitis drug therapy trials Gut, 2004
- Meta-Analysis of First-Line Triple Therapy forHelicobacter pyloriEradication in Korea: Is It Time to Change? Journal of Korean Medical Science, 2014
- Use of acid-suppressive drugs and risk of pneumonia: a systematic review and meta-analysis Canadian Medical Association Journal, 2010
- A systematic review of Helicobacter pylori eradication treatment schedules in children Alimentary Pharmacology & Therapeutics, 2000
- Systematic review: impaired drug absorption related to the co‐administration of antisecretory therapy Alimentary Pharmacology & Therapeutics, 2009
- PPI versus Histamine H2 Receptor Antagonists for Prevention of Upper Gastrointestinal Injury Associated with Low-Dose Aspirin: Systematic Review and Meta-analysis PLoS ONE, 2015
- External Validation of a Measurement Tool to Assess Systematic Reviews (AMSTAR) PLoS ONE, 2007
- Instruments evaluating the clinical findings of laryngopharyngeal reflux: A systematic review The Laryngoscope, 2018
- Head-to-head comparison of H2-receptor antagonists and proton pump inhibitors in the treatment of erosive esophagitis: A meta-analysis World Journal of Gastroenterology, 2005
- Systematic review: maintenance treatment of gastro‐oesophageal reflux disease with proton pump inhibitors taken ‘on‐demand’ Alimentary Pharmacology & Therapeutics, 2007
- Treatment of helicobacter pylori infection- a review Indian Journal of Pharmacology, 2001
- Inhibition of Aspirin-Induced Gastrointestinal Injury: Systematic Review and Network Meta-Analysis Frontiers in Pharmacology, 2021
- Comment on “Individual Proton Pump Inhibitors and Outcomes in Patients With Coronary Artery Disease on Dual Antiplatelet Therapy: A Systematic Review” Revista Portuguesa de Cardiologia (English Edition), 2016
- Antacid therapy for gastroesophageal reflux in preterm infants: a systematic review BMJ Paediatrics Open, 2018
- Influence of Cytochrome P450 2C19 Genotype on Helicobacter pylori Proton Pump Inhibitor-Amoxicillin-Clarithromycin Eradication Therapy: A Meta-Analysis Frontiers in Pharmacology, 2021
- Comparison Among Proton Pump Inhibitor Inducing Pneumonia in Hospital: Narrative Review Majalah Farmaseutik, 2024
- S561 Vonoprazan Is Superior to a Proton Pump Inhibitor in Healing Severe Erosive Esophagitis: A Meta-Analysis of Randomized Controlled Trials The American Journal of Gastroenterology, 2023
- Efficacy of PPI-containing Helicobacter pylori Eradication Regimens and Gastric Cancer Risk Associated with Long-term PPI Use: A Meta-analysis and Network Meta-analysis Korean Journal of Clinical Pharmacy, 2026
- A Systematic Literature Review and Economic Evaluation with a Meta-Analysis of Randomized Control Trials Focusing on Symptom Reduction in Adults Ages 18 and Older Treated by Either Esomeprazole, Omeprazole, Lansoprazole, Rabeprazole, or Pantroprazole for Diagnosed Reflux Disease in North America and Europe The Medicine Forum, 2018
- A review article on sublingual tablet of lansoprazole Journal of Pharmacognosy and Phytochemistry, 2019
- Self-Management of Reflux-Like Symptoms: A Patient-Centered Decision-Making Approach Digestive diseases (Basel, Switzerland), 2026
- Clopidogrel vs. Aspirin in Double Antithrombotic Therapy for Patients on Oral Anticoagulation Undergoing Coronary Stenting Journal of cardiovascular development and disease, 2026
- A Comprehensive Review on the Efficacy and Safety of Vonoprazan in the Management of Gastric Acid-Related Diseases Cureus, 2024
- Solidification of SNEDDS Using Mesoporous Carriers (2020-2025): A Review of Design, Biopharmaceutical Enhancement, and Therapeutic Impact Drug design, development and therapy, 2025
- Disease mechanisms and translational barriers guide nanocarrier design for nose to brain delivery in Alzheimer's disease Discover nano, 2026
- Research progress on potential high-risk drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis with insights from adverse drug reaction database mining Frontiers in pharmacology, 2026
- Selected Medicines That Can Cause Cardiac Arrest with Asystole Current issues in molecular biology, 2025
- Long-Term Proton Pump Inhibitor Therapy and Risk of Gastric Atrophy and Precancerous Mucosal Changes: A Systematic Review Cureus, 2025
- Rebamipide in gastric mucosal protection and healing: An Asian perspective World journal of gastrointestinal pharmacology and therapeutics, 2025
